DiagnaMed Holdings Corp. has appointed John Karagiannidis as its new President and CEO, replacing Fabio Chianelli, who will transition to a role on the Board of Directors. This leadership change is part of DiagnaMed's strategy to strengthen its partnership with Quebec Innovative Materials Corp. (QIMC) and enhance its efforts in natural hydrogen exploration in Ontario. The company aims to accelerate regional hydrogen development by leveraging a collaborative exploration model with QIMC and the Institut National de la Recherche Scientifique.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.